These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10205855)

  • 1. Determination of bezafibrate concentration by high performance liquid-chromatography in serum of rats treated with lead nitrate.
    Anchisi C; Fadda AM; Maccioni AM; Dessì S
    Farmaco; 1998; 53(10-11):690-2. PubMed ID: 10205855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPLC determination of bezafibrate in human plasma and its application to pharmacokinetics studies.
    de Melo J; Hurtado FK; Poitevin FS; Flores FC; Zimmermann ES; Dalmora SL; Rolim CM
    J Chromatogr Sci; 2010; 48(5):362-6. PubMed ID: 20515529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of bezafibrate, ciprofibrate and fenofibric acid in human plasma by high-performance liquid chromatography.
    Masnatta LD; Cuniberti LA; Rey RH; Werba JP
    J Chromatogr B Biomed Appl; 1996 Dec; 687(2):437-42. PubMed ID: 9017468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPLC method for the determination of bezafibrate in human plasma and application to a pharmacokinetic study of bezafibrate dispersible tablet.
    Wei Z; Bing-ren X; Ying Z; Liyan Y; Teng W; Cai-yun W
    J Chromatogr Sci; 2008; 46(10):844-7. PubMed ID: 19007489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits.
    Ou J; Saku K; Jimi S; Liao YL; Ohta T; Zhang B; Arakawa K
    Jpn Circ J; 1999 Jun; 63(6):471-7. PubMed ID: 10406588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary lipids, lithogenic index and biliary drug concentrations during etofibrate and bezafibrate treatment.
    Raedsch R; Plachky J; Wolf N; Simonis G
    Eur J Drug Metab Pharmacokinet; 1995; 20(2):113-8. PubMed ID: 8582435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood monitoring of bezafibrate in a chronic hemodialysis patient.
    Takeda K; Nakamoto M; Yasunaga C; Nishihara G; Matsuo K; Urabe M; Goya T
    Nephron; 1997; 76(4):487-8. PubMed ID: 9274850
    [No Abstract]   [Full Text] [Related]  

  • 8. Decrease in hepatotoxicity by lead exposure is not explained by its mitogenic response.
    Calabrese EJ; Baldwin LA; Leonard DA; Zhao XQ
    J Appl Toxicol; 1995; 15(2):129-32. PubMed ID: 7782558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of bezafibrate in human plasma and urine by high-performance liquid chromatography.
    Castoldi D; Monzani V; Tofanetti O
    J Chromatogr; 1985 Nov; 344():259-65. PubMed ID: 4086546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isolation of a bacterial strain capable of bezafibrate-degrading and biodegradation characteristics].
    Yang X; Xue G; Zhao X; Liu Y
    Wei Sheng Wu Xue Bao; 2010 Jun; 50(6):797-802. PubMed ID: 20687346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady-state kinetics of bezafibrate and clofibrate in healthy female volunteers.
    Abshagen U; Spörl-Radun S; Marinow J
    Eur J Clin Pharmacol; 1980 Apr; 17(4):305-8. PubMed ID: 6995131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of bioavailable peroxisome proliferator-activated receptor gamma modulators by a cell-based luciferase reporter system.
    del Bas JM; Laos S; Caimari A; Crescenti A; Arola L
    Anal Biochem; 2012 Aug; 427(2):187-9. PubMed ID: 22613053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate.
    Kyrklund C; Backman JT; Kivistö KT; Neuvonen M; Laitila J; Neuvonen PJ
    Clin Pharmacol Ther; 2001 May; 69(5):340-5. PubMed ID: 11372002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte proliferation induced in rats by lead nitrate is suppressed by several tumor necrosis factor alpha inhibitors.
    Kubo Y; Yasunaga M; Masuhara M; Terai S; Nakamura T; Okita K
    Hepatology; 1996 Jan; 23(1):104-14. PubMed ID: 8550029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrate prevents cisplatin-induced proximal tubule cell death.
    Nagothu KK; Bhatt R; Kaushal GP; Portilla D
    Kidney Int; 2005 Dec; 68(6):2680-93. PubMed ID: 16316343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of fluvastatin and bezafibrate on exercise metabolism: a placebo-controlled study in healthy normolipidaemic subjects.
    Eagles CJ; Kendall MJ; Maxwell S
    Br J Clin Pharmacol; 1996 May; 41(5):381-7. PubMed ID: 8735678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA hypomethylation during liver cell proliferation induced by a single dose of lead nitrate.
    Rossiello MR; Aresta AM; Prisco M; Kanduc D
    Boll Soc Ital Biol Sper; 1991 Dec; 67(12):993-7. PubMed ID: 1840801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic GABA receptor functional regulation and liver cell proliferation.
    Biju MP; Pyroja S; Rajeshkumar NV; Paulose CS
    Mol Cell Biochem; 2001 Jan; 216(1-2):65-70. PubMed ID: 11216865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of highly water-soluble fibrate derivatives via BGLation.
    Nemoto H; Kamiya M; Nakamoto A; Matsushita T; Matsumura K; Hattori H; Kawamura T; Taoka C; Abe S; Ishizawa K; Miyamoto L; Tsuchiya K
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6425-8. PubMed ID: 22975299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bezafibrate-mizoribine interaction: Involvement of organic anion transporters OAT1 and OAT3 in rats.
    Feng Y; Wang C; Liu Q; Meng Q; Huo X; Liu Z; Sun P; Yang X; Sun H; Qin J; Liu K
    Eur J Pharm Sci; 2016 Jan; 81():119-28. PubMed ID: 26474691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.